The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels.
Kerb R, Aynacioglu AS, Brockmöller J, Schlagenhaufer R, Bauer S, Szekeres T, Hamwi A, Fritzer-Szekeres M, Baumgartner C, Ongen HZ, Güzelbey P, Roots I, Brinkmann U.
Kerb R, et al. Among authors: bauer s.
Pharmacogenomics J. 2001;1(3):204-10. doi: 10.1038/sj.tpj.6500025.
Pharmacogenomics J. 2001.
PMID: 11908757